Strategic Partners A/S

CPH • Healthcare • Biotechnology • Quote as of 10/23/2026 16:40

Company Profile

IndustryBiotechnology

SectorHealthcare

ExchangeCPH

Market Capitalization35.98 mln

Float0.04 mln

Earnings Date11/20/2026

Business Description

Founded in 2009 and headquartered in Herlev, Denmark, Strategic Partners A/S is a shell company with no meaningful business activity currently underway. The company spent years working in biotechnology under its previous name, Orphazyme A/S, before rebranding in October 2024.

Key Fundamentals

EPS31.47

P/E19.07

ROE7.23

RPS7.28

ROIC-53.88

ROA6.91

EBITDA, mln1.35

EV / EBITDA13.24

EV / EBIT13.24

Revenue, mln0.41

EV / Revenue43.60

Quote Details

Last 650.00

Change 10 (1.56%)

Open 600.00

Volume 3

Turnover 1,950

Average Volume 23.71

Financial Ratios

Pre-Tax Profit Margin329

Leverage Ratio1.04

Current Ratio23.55

Price / Book1.40

Price / Tangible Book1.40

Price / Cash Flow24.06

Price / Free Cash Flow23.51

Price / Sales66.29

PEG Ratio0.26

Financial Strength

Altman Z-Score19.59

Piotroski F-Score 4 / 9

Price to Graham Number1.12

Price Performance & Relative Strength

Period	Price Performance	Relative Strength
1 Week	-0.76%	46 / 100
1 Month	-0.76%	40 / 100
2 Months	10.17%	88 / 100
6 Months	13.64%	81 / 100
1 Year	-45.61%	6 / 100

Strategic Partners A/S

Company Profile

EPS

P / E

Piotroski F-Score

Relative Strength

Pre-Tax Margin